Given its regenerative properties and favorable safety profile, AOD9604 holds promise as a novel therapeutic agent for OA, especially when used in conjunction with established treatments like HA [1]
Morning and evening both work
Drug Interactions: Certain medications, like metformin and stomach acid reducers (PPIs), can interfere with B12 absorption from food, which may increase the need for injections
Acute gallbladder disease: Cases (e.g., gallstones) have been reported
It is suitable for use within metabolic research frameworks, cellular pathway investigations, and biochemical testing environments requiring controlled preparation of lyophilised research materials
Dosing schedules may vary depending on patient goals, metabolic health, and physician guidance